Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$57.09
neg -0.51
-0.89%
Today's Range: 56.88 - 58.03 | MRK Avg Daily Volume: 11,091,300
Last Update: 04/27/15 - 3:59 PM EDT
Volume: 10,375,045
YTD Performance: 1.27%
Open: $57.83
Previous Close: $57.60
52 Week Range: $52.49 - $63.62
Oustanding Shares: 2,838,192,933
Market Cap: 162,664,352,331
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 7 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.08 2.08 2.00 2.00
Latest Dividend: 0.45
Latest Dividend Yield: 3.13%
Dividend Ex-Date: 03/12/15
Price Earnings Ratio: 14.13
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
14.13 14.10 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.97% 0.17% 50.27%
GROWTH 12 Mo 3 Yr CAGR
Revenue -4.10 -0.12 -0.04
Net Income 164.20 0.87 0.23
EPS 176.90 1.02 0.26
Earnings for MRK:
EBITDA 13.37B
Revenue 42.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.75 $0.79 $3.39 $3.76
Number of Analysts 7 6 12 10
High Estimate $0.82 $0.81 $3.46 $3.97
Low Estimate $0.70 $0.75 $3.28 $3.43
Prior Year $0.88 $0.85 $3.49 $3.39
Growth Rate (Year over Year) -14.77% -7.25% -2.79% 10.98%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Peltier

 | Apr 27, 2015 | 4:55 PM EDT

Apple is higher after-hours on better-than-expected results.

By

David Peltier

 | Apr 24, 2015 | 4:33 PM EDT

Big day for Microsoft -- Xerox, not so much.

By

Jim Cramer

 | Apr 24, 2015 | 11:22 AM EDT

Biogen miss no reason to abandon big 4 of Big Pharma.

By

Robert Lang

 | Apr 22, 2015 | 10:52 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Robert Lang

 | Apr 22, 2015 | 10:00 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Jim Cramer

 | Apr 16, 2015 | 12:54 PM EDT

The only cable/entertainment company that isn't overvalued.

By

Bob Byrne

 | Apr 8, 2015 | 7:00 AM EDT

What moves stock index futures.

By

Bob Byrne

 | Apr 7, 2015 | 7:00 AM EDT

The bulls deserve every benefit of the doubt.

By

Jim Cramer

 | Apr 3, 2015 | 10:57 AM EDT

The jobs report actually indicates the dollar has peaked. 

By

Jim Cramer

 | Mar 31, 2015 | 11:33 AM EDT

Combined Heinz-Kraft heads a long second-quarter list.

Points well taken.

Hi Doug, your point is well taken - it's true that the relationship between the dollar and...
Hard to tell as Beats is lumped in with iPod and Apple TV -- but stripping away weak sales...

Okay, $140 billion? That's just sick lol.

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.